Chase Investment Counsel Corp purchased a new stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 15,000 shares of the semiconductor company's stock, valued at approximately $1,048,000.
Other hedge funds have also modified their holdings of the company. Avior Wealth Management LLC lifted its stake in shares of Axcelis Technologies by 1,153.8% during the 4th quarter. Avior Wealth Management LLC now owns 489 shares of the semiconductor company's stock valued at $34,000 after buying an additional 450 shares in the last quarter. Capital Advisors Ltd. LLC lifted its position in shares of Axcelis Technologies by 1,415.2% in the fourth quarter. Capital Advisors Ltd. LLC now owns 500 shares of the semiconductor company's stock valued at $35,000 after acquiring an additional 467 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Axcelis Technologies by 85.5% in the fourth quarter. Blue Trust Inc. now owns 627 shares of the semiconductor company's stock worth $44,000 after acquiring an additional 289 shares during the period. Truvestments Capital LLC purchased a new stake in shares of Axcelis Technologies during the third quarter worth about $69,000. Finally, Palouse Capital Management Inc. bought a new stake in Axcelis Technologies during the 4th quarter valued at approximately $79,000. 89.98% of the stock is currently owned by institutional investors.
Axcelis Technologies Trading Up 4.0 %
Shares of NASDAQ ACLS traded up $2.24 during midday trading on Wednesday, hitting $58.54. The company's stock had a trading volume of 563,619 shares, compared to its average volume of 667,193. Axcelis Technologies, Inc. has a 12-month low of $53.67 and a 12-month high of $158.61. The company has a current ratio of 5.41, a quick ratio of 4.05 and a debt-to-equity ratio of 0.04. The firm has a market cap of $1.90 billion, a P/E ratio of 9.52, a price-to-earnings-growth ratio of 4.52 and a beta of 1.52. The business's 50 day moving average is $66.90 and its two-hundred day moving average is $82.41.
Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last released its earnings results on Monday, February 10th. The semiconductor company reported $1.54 earnings per share for the quarter, topping the consensus estimate of $1.25 by $0.29. Axcelis Technologies had a return on equity of 21.02% and a net margin of 19.75%. As a group, equities research analysts expect that Axcelis Technologies, Inc. will post 2.55 EPS for the current year.
Analysts Set New Price Targets
Several research analysts have weighed in on ACLS shares. William Blair lowered shares of Axcelis Technologies from an "outperform" rating to a "market perform" rating in a report on Wednesday, February 12th. Benchmark cut shares of Axcelis Technologies from a "buy" rating to a "hold" rating in a research note on Friday, November 8th. Needham & Company LLC reiterated a "hold" rating on shares of Axcelis Technologies in a research note on Wednesday, February 12th. Finally, Craig Hallum cut their price objective on Axcelis Technologies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Wednesday, January 15th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $154.00.
View Our Latest Research Report on ACLS
Axcelis Technologies Profile
(
Free Report)
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
See Also

Before you consider Axcelis Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axcelis Technologies wasn't on the list.
While Axcelis Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.